The Balm In Gilead and Alnylam Pharmaceuticals present an Educational Webinar about Hereditary ATTR Amyloidosis on June 12, 2024 at 7pm ET

In partnership with The Balm in Gilead and Alnylam Pharmaceuticals, the goal of this webinar is to provide education about hereditary ATTR (hATTR) amyloidosis, a rare condition disproportionately affecting African Americans.

Join us to hear from Alnylam Patient Education Liaison Christine and Tab, a patient living with this inherited disease. Approximately 1 in 25 (4%) of African Americans have a certain genetic variant associated with hATTR amyloidosis. Learn how to recognize the signs and symptoms of the disease, how it’s passed down, and where to find additional educational resources.

There is no cost to attend this virtual event.

Registrants’ contact information will be held confidential by The Balm in Gilead and will not be shared with the sponsor, speakers, or anyone outside of The Balm In Gilead. By registering for this event, sponsored by Alnylam Pharmaceuticals, the registrant further agrees to the Alnylam Privacy Policy. The Alnylam Data Privacy Policy can be found at: https://alnylampolicies.com/privacy. The registrant confirms to be 18 years or older, a US resident, and consents to the processing of their personal data per the terms outlined in the Data Privacy Notification and Consent.

© 2024 Alnylam Pharmaceuticals, Inc. All rights reserved. TTR-USA-00470

Speakers:

Christine –  Alnylam Patient Education Liaison at Alnylam Pharmaceuticals

Tab – Living with hATTR amyloidosis